30627663|t|The Mixed-Lineage Kinase Inhibitor URMC-099 Protects Hippocampal Synapses in Experimental Autoimmune Encephalomyelitis.
30627663|a|Treatments to stop gray matter degeneration are needed to prevent progressive disability in multiple sclerosis (MS). We tested whether inhibiting mixed-lineage kinases (MLKs), which can drive inflammatory microglial activation and neuronal degeneration, could protect hippocampal synapses in C57BL/6 mice with experimental autoimmune encephalomyelitis (EAE), a disease model that recapitulates the excitatory synaptic injury that occurs widely within the gray matter in MS. URMC-099, a broad spectrum MLK inhibitor with additional activity against leucine-rich repeat kinase 2 (LRRK2) and other kinases, prevented loss of PSD95-positive postsynaptic structures, shifted activated microglia toward a less inflammatory phenotype, and reversed deficits in hippocampal-dependent contextual fear conditioning in EAE mice when administered after the onset of motor symptoms. A narrow spectrum inhibitor designed to be highly selective for MLK3 failed to protect synapses in EAE hippocampi, and could not rescue cultured neurons from trophic deprivation in an in vitro model of MLK-driven neuronal degeneration. These results suggest that URMC-099 may have potential as a neuroprotective treatment in MS and demonstrate that a broad spectrum of inhibition against a combination of MLK and other kinases is more effective in neuroinflammatory disease than selectively targeting a single kinase.
30627663	35	43	URMC-099	Chemical	MESH:C583037
30627663	77	118	Experimental Autoimmune Encephalomyelitis	Disease	MESH:D004681
30627663	139	163	gray matter degeneration	Disease	MESH:D002549
30627663	186	208	progressive disability	Disease	MESH:D018450
30627663	212	230	multiple sclerosis	Disease	MESH:D009103
30627663	232	234	MS	Disease	MESH:D009103
30627663	312	324	inflammatory	Disease	MESH:D007249
30627663	325	335	microglial	Disease	
30627663	351	372	neuronal degeneration	Disease	MESH:D009410
30627663	412	419	C57BL/6	CellLine	CVCL:C0MU
30627663	420	424	mice	Species	10090
30627663	430	471	experimental autoimmune encephalomyelitis	Disease	MESH:D004681
30627663	473	476	EAE	Disease	MESH:D004681
30627663	529	544	synaptic injury	Disease	MESH:D012183
30627663	590	592	MS	Disease	MESH:D009103
30627663	594	602	URMC-099	Chemical	MESH:C583037
30627663	621	624	MLK	Gene	18198
30627663	668	696	leucine-rich repeat kinase 2	Gene	66725
30627663	698	703	LRRK2	Gene	66725
30627663	742	747	PSD95	Gene	13385
30627663	824	836	inflammatory	Disease	MESH:D007249
30627663	927	930	EAE	Disease	MESH:D004681
30627663	931	935	mice	Species	10090
30627663	1053	1057	MLK3	Gene	26403
30627663	1088	1091	EAE	Disease	MESH:D004681
30627663	1191	1194	MLK	Gene	18198
30627663	1202	1223	neuronal degeneration	Disease	MESH:D009410
30627663	1252	1260	URMC-099	Chemical	MESH:C583037
30627663	1314	1316	MS	Disease	MESH:D009103
30627663	1394	1397	MLK	Gene	18198
30627663	1437	1462	neuroinflammatory disease	Disease	MESH:D000090862
30627663	Negative_Correlation	MESH:C583037	MESH:D007249
30627663	Association	MESH:D000090862	18198
30627663	Association	MESH:D009410	18198
30627663	Negative_Correlation	MESH:C583037	13385
30627663	Negative_Correlation	MESH:C583037	MESH:D009103
30627663	Negative_Correlation	MESH:C583037	18198
30627663	Negative_Correlation	MESH:C583037	MESH:D004681
30627663	Negative_Correlation	MESH:C583037	66725

